Bio Sequence

Biological Glossary | What is Motif?

9 November 2023
2 min read

Motifs in biology refer to nucleotide or amino-acid sequence patterns that are prevalent and usually associated with the biological function of a macromolecule. They can occur in the exon of a gene, encoding the structural motif of a protein, or in other areas such as regulatory sequence motifs or satellite DNA. They don't necessarily have to possess a distinctive secondary structure. Some motifs may affect the shape of nucleic acids. Short coding motifs can label proteins for cell delivery or mark them for phosphorylation. Researchers can find motifs in a sequence or database using bioinformatic techniques like BLAST. Sequence motifs are short recurring patterns in DNA presumed to have a biological function, often indicating sequence-specific binding sites for proteins, or being involved in RNA level processes.

Free registration is available for the Bio biological sequence database: https://bio.patsnap.com. Act now to expedite your sequence search tasks.

图片包含 图示

描述已自动生成

Biological Glossary | What is Chemical Modification?
Bio Sequence
2 min read
Biological Glossary | What is Chemical Modification?
9 November 2023
Chemical modifications in biology refer to the changes in biomolecular structure and function brought about by the addition or removal of modifying elements.
Read →
IDRx shares initial findings from its ongoing Phase 1 StrateGIST trial at CTOS 2023, illustrating the promise of IDRX-42 for GIST patients
Latest Hotspot
3 min read
IDRx shares initial findings from its ongoing Phase 1 StrateGIST trial at CTOS 2023, illustrating the promise of IDRX-42 for GIST patients
9 November 2023
IDRx, Inc. has reported initial clinical results from its ongoing Phase 1 StrateGIST trial of IDRX-42. This trial is for patients with metastatic and/or inoperable gastrointestinal stromal tumors who have previously received at least one tyrosine kinase inhibitor therapy regime, now testing a higher dosage.
Read →
Research, Patent, and Literature Data behind the Early ADC Drug ORM-6151 Purchased by Bristol-Myers Squibb at a Huge Cost
Bio Sequence
3 min read
Research, Patent, and Literature Data behind the Early ADC Drug ORM-6151 Purchased by Bristol-Myers Squibb at a Huge Cost
9 November 2023
ORM-6151 is a monoclonal antibody drug that targets CD33 and GSPT1, developed by Orum Therapeutics.
Read →
Fresenius Kabi introduces Tyenne*, the inaugural EU-sanctioned tocilizumab biosimilar
Latest Hotspot
3 min read
Fresenius Kabi introduces Tyenne*, the inaugural EU-sanctioned tocilizumab biosimilar
9 November 2023
Fresenius Kabi made an announcement about the introduction of Tyenne®, its tocilizumab biosimilar which references the RoActemra® (tocilizumab) in the European Union.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.